An aqueous injectable suspension uses moxidectin microspheres and isoxazoline particles to extend parasite control while reducing injection site irritation.
A short-course KAF156 regimen maintains parasiticidal serum levels against resistant malaria while simplifying dosing and improving adherence.
A plant cell culture route boosts and purifies tormentic acid ester production to deliver lower-toxicity antitrypanosomal compositions.
A synthetic Sm14 gene with AOX1 and GAP promoters boosts Pichia pastoris yield while avoiding methanol-driven cost and stability limits.
Selective anti-Giardia activity lets mavelertinib clear infection while limiting mammalian toxicity, side effects, and gut dysbiosis.
Targeting ubiquitous Src interrupts parasite signaling and enables autophagic Toxoplasma degradation in EGFR-positive and EGFR-negative cells.
A multivalent vaccine combines filarial antigens and an adjuvant to address resistance, noncompliance, and weak single-antigen protection.
Timed water withholding and a two-hour access window help chicks consume diluted live Eimeria oocysts before settlement reduces uptake.
Anisolactone overcomes drug resistance in Plasmodium falciparum with high selectivity and minimal host toxicity.
Adamantane derivatives interfere with host cell mechanisms to treat leishmaniasis, reducing toxicity and drug resistance.
Vaccinating cattle with recombinant thrombostasin isoforms triggers specific immunity to reduce blood uptake by horn flies.
Switching tetrandrine from di-acid salt to free base form resolves the solubility versus absorption rate trade-off, enabling sustained plasma concentrations.
Combines 2-desoxoparaherquamide with abamectin to treat parasitic infestations in mammals.
Verapamil mediates parasite susceptibility to restore antiparasitic efficacy against resistant strains without increasing drug toxicity.
Targeting glutathione S-transferase, the compound overcomes drug resistance in Plasmodium falciparum parasites.
Nanoparticle-conjugated recombinant Eimeria proteins overcome weak immunogenicity of peptide vaccines by enhancing uptake at mucosal surfaces.
Mineral oil adjuvant with specific hydrocarbon chain distribution and P/N ratio stimulates balanced immune response while reducing toxicity.
TMP-r1 protein antigens stimulate host immune responses to reduce tick attachment, addressing the complexity of identifying effective vaccine candidates.
Vitamin E shields isoxazoline from hypochlorite oxidation, maintaining parasiticidal efficacy and extending pharmaceutical shelf life.
RNA aptamers access inaccessible PfEMP1 epitopes, disrupting rosettes and offering stable anti-sequestration therapy.
Subcutaneous isoxazoline administration bypasses wool barriers to treat chewing lice in sheep, eliminating labor-intensive topical applications.
A synergistic essential oil composition combining thymol, linalool, and trans-anethole to deliver potent antiparasitic activity against resistant parasites.